cupric chloride has been researched along with amyloid beta-peptides in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrisano, V; Bartolini, M; Bolognesi, ML; Cavalli, A; Melchiorre, C; Recanatini, M; Rosini, M; Valgimigli, L | 1 |
| Akkaraju, G; da Costa, VCP; Gonzalez, P; Green, KN; Pota, K; Turan, LS | 1 |
| Hureau, C; Liu, Y; Meunier, B; Robert, A; Zhang, W | 1 |
3 other study(ies) available for cupric chloride and amyloid beta-peptides
| Article | Year |
|---|---|
Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Binding Sites; Butyrylcholinesterase; Chelating Agents; Cholinesterase Inhibitors; Copper; Drug Design; Ferric Compounds; Humans; Ligands; Models, Molecular; Peptide Fragments; Structure-Activity Relationship; Tacrine; Thermodynamics | 2007 |
Synthesis, Characterization, and Activity of a Triazine Bridged Antioxidant Small Molecule.
Topics: Amyloid beta-Peptides; Animals; Antioxidants; Benzopyrans; Cell Line, Transformed; Chelating Agents; Copper; Drug Evaluation, Preclinical; Fluorometry; Mice; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Neurons; Neuroprotective Agents; Peptide Fragments; Protein Binding; Protein Conformation; Structure-Activity Relationship; Tyrosine | 2017 |
N
Topics: Aminoquinolines; Amyloid beta-Peptides; Ascorbic Acid; Carrier Proteins; Chelating Agents; Chlorides; Copper; Homeostasis; Humans; Molecular Structure; Oxidation-Reduction; Oxidative Stress; Peptide Fragments; Reactive Oxygen Species; Zinc Compounds | 2018 |